User Reviews for Stalevo
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Stalevo.
|Parkinson's Disease||5 reviews||49 medications|
|Summary of Stalevo reviews||5 reviews||6.0|
Reviews for Stalevo
For Parkinson's Disease "My father was put on Stalevo and had to discontinue use after suffering side effects which came on after dosage was raised in succession. He has had severe side effects such as fatigue, diarrhea and he could barely function. He is no longer on the medication."
Daughter of user August 25, 2010
11 users found this comment helpful.
For Parkinson's Disease "I was put on Stalevo and threw up for 2 days. First night hallucinations and insomnia. I read where if a history of melanoma you should not take this medicine. I do have history so called my neurologist and discontinued this medication."
jackieq April 10, 2010
10 users found this comment helpful.
For Parkinson's Disease "I have had PD since age 39. I have been taking Stalevo since available. It has worked wonders for me as long as I don't forget to take it. I tried all three compmonents of Stalevo as individual pills, and they did not work for me like their combination in Stalevo. Highly recommend."
Luvstosew February 16, 2010
12 users found this comment helpful.
For Parkinson's Disease "Has helped with all of my symptoms and other problems, which I wasn't sure whether it was the disease or side effects of the agonists (Requip and Mirapex) I had taken before."
wv_picker September 4, 2009
15 users found this comment helpful.
For Parkinson's Disease "No noticeable side effects."
Anonymous February 20, 2009
13 users found this comment helpful.
More about Stalevo (carbidopa / entacapone / levodopa)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 5 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents